CD274 and gastric cancer: Several predictive tumor biomarkers from biopsy tissue samples could indicate ICI treatment response and prognosis of gastric cancer patients (6), such as positivity of programmed death-ligand 1 (PD-L1), mismatch repair deficiency (dMMR), and Epstein–Barr virus (EBV) (6, 7).